Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-061116
Filing Date
2025-04-30
Accepted
2025-04-30 16:30:16
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sln-20241231.htm   iXBRL 10-K/A 943121
2 EX-10.13 sln-ex10_13.htm EX-10.13 116014
3 EX-10.14 sln-ex10_14.htm EX-10.14 109082
4 EX-10.15 sln-ex10_15.htm EX-10.15 116937
5 EX-31.3 sln-ex31_3.htm EX-31.3 5070
6 EX-31.4 sln-ex31_4.htm EX-31.4 5456
  Complete submission text file 0000950170-25-061116.txt   1793122

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20241231.xsd EX-101.SCH 72422
22 EXTRACTED XBRL INSTANCE DOCUMENT sln-20241231_htm.xml XML 17847
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 10-K/A | Act: 34 | File No.: 001-39487 | Film No.: 25895918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)